Transforming the diagnostic pathway from specimen collection and management to improved laboratory performance, enabling customers to deliver accurate diagnoses.
The portfolio is integrated in both clinical and lab processes and includes:
Specimen Management - Innovative solutions to acquire and transport different specimen types ensuring sample quality while improving total cost of ownership and patient convenience.
Microbiology - Transforming the microbiology laboratory with an extensive portfolio of microbiology solutions designed as integrated, end-to- end offerings, to enhance testing while streamlining workflows to improve outcomes and reduce overall costs.
Molecular and Women’s Health & Cancer - Integrated and automated tools for laboratories to analyse sequences in the genome and proteome that support infectious disease diagnosis and advance cervical cancer screening and management.
Point of Care - Rapid immunoassay platform to drive decentralisation of care including the latest developments for flu, RSV and Group A Strep.
The Commission’s role is to lead and coordinate national improvements in the safety and quality of health care. The Commission works in partnership with the Australian Government, state and territory governments and the private sector to achieve a safe, high-quality and sustainable health system. In doing so, the Commission also works closely with patients, carers, clinicians, managers, policymakers and healthcare organisations.
Key functions of the Commission include developing national safety and quality standards, developing clinical care standards to improve the implementation of evidence-based health care, coordinating work in specific areas to improve outcomes for patients, and providing information, publications and resources about safety and quality.
Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people.
The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis and cancer.
Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.
Based in Melbourne, Gilead Sciences Australia and New Zealand employs over 100 people.
BioMérieux, a global leader in in-vitro diagnostics, present in more than 160 countries worldwide. For 60 years, BioMérieux is driven by a pioneering spirit and unrelenting commitment to provide innovative diagnostic solutions that improve patient health. The patient is at the center of our strategy of developing products with high medical and economic value. Our extensive Antimicrobial Stewardship (AMS) diagnostics range supports appropriate antibiotic use, helping to preserve their efficacy and curb antibiotic resistance. Putting diagnostics at the heart of Antimicrobial Stewardship helps drive informed therapy decisions, providing actionable results to the clinician at every stage of the patient’s healthcare pathway: from initiation of antibiotic therapy, to treatment adjustment and optimization and finally for antibiotic discontinuation.
Copan/Interpath Services
Copan
Copan is dedicated to developing high-quality and cutting-edge sample collection products for infectious diseases, human genomics, environmental and forensic applications, along with automated workflow solutions.Our ideas drove 40 years of progress in preanalytics, resulting in meaningful products tailored to fit any need. Among them, FLOQ technology revolutionized sample collection, while WASPLab® advanced hardware and A.I. modules leveraged automation and digitalization to redefine full lab automation.
Copan's Workflow-Integrated System Environment can accompany your biological samples from the collection to impeccable diagnostics, unlocking your lab's real potential and improving treatment indication and patient care. www.copangroup.com
Interpath Services
Interpath Services, a part of the Bunzl Group, is a market leader in the Australian Scientific Industry, specialising in the sale and distribution of Life Science Consumables for the Pathology, Hospital, Medical Research and Scientific markets. We represent some of the world's leading manufactures who specialise in these markets.Our foundation philosophy is to provide exceptional service, specialist advice, training and education to support your business and delivered in market by our highly trained industry expert team.
Making our company one of the most respected and successful Life Science supply companies in the market. www.interpath.com.au
P.O. Box 6705
East Perth 6892
Western Australia